MDxHealth SA

Healthcare · Diagnostics & Research · Belgium

Last price 0.1812 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.29M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company’s testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient’s previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options a...